SG Americas Securities LLC Lowers Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

SG Americas Securities LLC reduced its position in Doximity, Inc. (NASDAQ:DOCS) by 64.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,685 shares of the company’s stock after selling 10,348 shares during the quarter. SG Americas Securities LLC’s holdings in Doximity were worth $248,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. LRI Investments LLC purchased a new stake in Doximity during the 1st quarter worth approximately $27,000. Blue Trust Inc. grew its stake in shares of Doximity by 621.4% in the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock worth $37,000 after acquiring an additional 1,193 shares in the last quarter. Quarry LP grew its stake in shares of Doximity by 101.2% in the second quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after acquiring an additional 131,253 shares in the last quarter. DekaBank Deutsche Girozentrale purchased a new stake in shares of Doximity during the first quarter worth $46,000. Finally, First Horizon Advisors Inc. raised its stake in shares of Doximity by 80.0% in the second quarter. First Horizon Advisors Inc. now owns 1,710 shares of the company’s stock valued at $48,000 after acquiring an additional 760 shares in the last quarter. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Doximity

In other news, Director Kira Scherer Wampler sold 2,500 shares of the stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $28.18, for a total transaction of $70,450.00. Following the completion of the sale, the director now owns 10,258 shares in the company, valued at approximately $289,070.44. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Kira Scherer Wampler sold 2,500 shares of the business’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $28.18, for a total value of $70,450.00. Following the transaction, the director now owns 10,258 shares in the company, valued at $289,070.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Anna Bryson sold 30,000 shares of the stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $35.00, for a total value of $1,050,000.00. Following the sale, the chief financial officer now directly owns 309,627 shares of the company’s stock, valued at $10,836,945. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 35,451 shares of company stock worth $1,201,018. 39.40% of the stock is owned by company insiders.

Doximity Stock Down 3.5 %

NASDAQ:DOCS opened at $41.97 on Tuesday. Doximity, Inc. has a 52-week low of $19.89 and a 52-week high of $44.88. The stock’s 50 day moving average price is $39.61 and its 200 day moving average price is $31.42. The company has a market capitalization of $7.78 billion, a PE ratio of 58.29, a P/E/G ratio of 5.29 and a beta of 1.29.

Doximity (NASDAQ:DOCS) last announced its earnings results on Thursday, August 8th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.06. Doximity had a net margin of 32.53% and a return on equity of 19.26%. The business had revenue of $126.68 million for the quarter, compared to analyst estimates of $119.88 million. As a group, sell-side analysts anticipate that Doximity, Inc. will post 0.8 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on DOCS shares. Wells Fargo & Company cut Doximity from an “equal weight” rating to an “underweight” rating and lowered their target price for the stock from $27.00 to $19.00 in a research note on Thursday, July 18th. Barclays raised shares of Doximity from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $35.00 to $52.00 in a report on Tuesday, October 15th. Truist Financial reissued a “hold” rating and issued a $35.00 price objective (up from $31.00) on shares of Doximity in a research report on Wednesday, August 14th. Baird R W upgraded shares of Doximity to a “strong-buy” rating in a research note on Tuesday, September 17th. Finally, Robert W. Baird lifted their price target on Doximity from $41.00 to $45.00 and gave the stock an “outperform” rating in a report on Tuesday, September 17th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $35.83.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.